EUVIMEDEUVIMED entdecken
Crossref

Radiation responsive PROTAC nanoparticles for tumor-specific proteolysis enhanced radiotherapy

Mengxia Xu, Yuyang Yun, Changjun Li, Yiling Ruan, Osamu Muraoka, Weijia Xie iD, Xiaolian Sun iD

Journal of Materials Chemistry B · 2024 · 12 (13) · 3240-3248

DOI: 10.1039/d3tb03046f ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2024. Verfasst von Mengxia Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, School of Pharmacy, China Pharmaceutical Uni…. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An X-ray responsive RCNprotac with enhanced tumor accumulation for BRD4 proteolysis and enhanced radiosensitization is reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesHumansProteolysisNuclear ProteinsTranscription FactorsBromodomain Containing ProteinsCell Cycle Proteins

Substanzen

Nuclear ProteinsTranscription FactorsBRD4 protein, humanBromodomain Containing ProteinsCell Cycle Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, Key Laboratory of Drug Quality Control and Pharmacovigilance, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China. xiaolian_sun@cpu.edu.cn.
  • State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China. weijiaxie@cpu.edu.cn.
  • Faculty of Pharmacy, Kinki University, Higashiosaka, Osaka 577-8502, Japan.

ORCID-Profile: Weijia Xie, Xiaolian Sun

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • China Pharmaceutical University
  • Outstanding Youth Foundation of Jiangsu Province

Zitieren

APA

Xu, M., Yun, Y., Li, C., Ruan, Y., Muraoka, O., Xie, W., & Sun, X. (2024). Radiation responsive PROTAC nanoparticles for tumor-specific proteolysis enhanced radiotherapy. Journal of Materials Chemistry B, 12(13), 3240-3248. https://doi.org/10.1039/d3tb03046f

Vancouver

Xu M, Yun Y, Li C, Ruan Y, Muraoka O, Xie W, et al. Radiation responsive PROTAC nanoparticles for tumor-specific proteolysis enhanced radiotherapy. Journal of Materials Chemistry B. 2024;12(13):3240-3248. doi:10.1039/d3tb03046f

BibTeX
@article{Xu2024,
  author = {Xu, Mengxia and Yun, Yuyang and Li, Changjun and Ruan, Yiling and Muraoka, Osamu and Xie, Weijia and Sun, Xiaolian},
  title = {Radiation responsive PROTAC nanoparticles for tumor-specific proteolysis enhanced radiotherapy},
  journal = {Journal of Materials Chemistry B},
  year = {2024},
  volume = {12},
  number = {13},
  pages = {3240--3248},
  doi = {10.1039/d3tb03046f}
}
Kostenlos starten →